A new report from industry stakeholders follows up the Food and Drug Administration’s 2012 report on creating a national surveillance system to identify poorly performing medical devices.

The FDA recommended unique device identifiers, development of national registries for different types of devices, streamlining adverse event reporting and analysis, and new methods for evidence generation and assessment.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access